Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Epilepsy
•
Neurology
What is your preferred approach to medication trials for diagnosis of nonconvulsive status epilepticus?
Related Questions
When do you use wearable EEG or epilepsy detection devices for epilepsy management?
What AI products have you found helpful for EEG and epilepsy?
What markers on EEG can help predict/detect postoperative or ICU-related delirium?
How do you approach escalating anti-seizure medication treatment of patients with atypical seizure semiologies?
When do you target the thalamus for SEEG exploration or neuromodulation in patients with drug-resistant epilepsy?
How do you advise patients with epilepsy that are planning pregnancy and use invasive neuromodulation for treatment of their epilepsy?
Which factors help you choose between intermittent phenobarbital dosing versus continuous pentobarbital infusion for pharmacological burst suppression in refractory status epilepticus?
When do you consider switching a generic formulation antiseizure medication to the brand formulation?
When do you consider long-term anti-seizure medication for patients who have an acute symptomatic seizure in the setting of a cerebrovascular event?
How do you approach tapering high dose continuous infusions for status epilepticus in patients experiencing serious medication-related toxicity?
